German version of the Unité Rhumatologique des Affections de la Main (URAM) scale in Dupuytren's disease: the need for a uniform definition of recurrence. Comment on the article by Beaudreuil et al.

摘要

We read with great interest the recent article in Arthritis Care & Research by Beaudreuil and coworkers regarding the validation of a Dupuytren's disease-specific short questionnaire to assess patient-reported functional outcome (1). We fully agree with the authors that measures to assess patient-reported outcome are paramount, especially in a disease like Dupuytren's contracture. However, we do not fully agree that validated outcome measures such as the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire and especially the Michigan Hand Questionnaire (MHQ) and its recently released short-form version (brief-MHQ) (2) are inferior in Dupuytren's disease because they are nonspecific.